Sterling Pharma Solutions is a CDMO of peptides based in UK. Direct manufacturer. Founded 2005. Key products include high potency APIs, hazardous chemistry.
Listing reviewed September 2026.
UK-based CDMO focused on peptide development and manufacturing under GLP/GMP standards. Provides pur
Directory assessment: Sterling Pharma Solutions is listed as a CDMO in the peptide supply chain, serving Europe markets from UK. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a medium confidence score — verification signals are present, but the listing is newer or less documented; perform standard due diligence before engaging.